FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2573251110> ?p ?o ?g. }

• W2573251110 abstract "Background Pertuzumab is a humanized monoclonal antibody that binds to HER2 at an epitope that prevents HER2 from dimerizing with ligand-activated HER-family receptors. To assess the potential of pertuzumab as a new therapy, the expression status of HER family members was determined in biliary tract carcinoma (BTC), and the antitumor activity of pertuzumab was investigated by assessing the inhibition of BTC cell growth. Methods The expression status of HER family members in 113 archival specimens of BTC was analyzed by using immunohistochemistry and fluorescence in situ hybridization. Using ten BTC cell lines, heregulin-alpha (HRG-a) stimulated cell proliferation and its inhibition by pertuzumab was tested in vitro. The phosphorylated HER family proteins and their respective downstream molecules were analyzed. In vivo antitumor activity of pertuzumab was evaluated in a xenograft model. Results Protein overexpression of HER2 and/or HER3 was observed in 23–34 % of the specimens and gene amplification in 17–27 %. Seven of the ten cell lines showed HER2 and/or HER3 protein overexpression and gene amplification, and HRG-a stimulated cell proliferation was observed in four of the ten cell lines. In a BTC cell line co-overexpressing HER2 and HER3, pertuzumab potently inhibited the HRG-a stimulated cell proliferation in a dose-dependent manner, and completely blocked the phosphorylation of HER3. Suppression of downstream pathway molecules including p-AKT was also observed. Pertuzumab inhibited the in vivo growth of subcutaneous tumors, and increased the number of apoptotic cancer cells. Conclusions Pertuzumab exerts potent antitumor activity in BTC cells co-overexpressing HER2 and HER3. Pertuzumab provides a new therapeutic option against BTC." @default.
• W2573251110 created "2017-01-26" @default.
• W2573251110 creator A5080246490 @default.
• W2573251110 date "2015-01-01" @default.
• W2573251110 modified "2023-09-27" @default.
• W2573251110 title "Overexpression and gene amplification of EGFR, HER2, and HER3 in biliary tract carcinomas, and the possibility for therapy with the HER2-targeting antibody pertuzumab Toru KawamotoKazunori IshigeMelanie ThomasYoriko Yamashita-Kashima • Sei ShuNobuyuki IshikuraShunichi AriizumiMasakazu Yamamoto •" @default.
• W2573251110 cites W1506285409 @default.
• W2573251110 cites W1913865396 @default.
• W2573251110 cites W1963537359 @default.
• W2573251110 cites W1964321121 @default.
• W2573251110 cites W1965164402 @default.
• W2573251110 cites W1968371031 @default.
• W2573251110 cites W1973701648 @default.
• W2573251110 cites W1974024530 @default.
• W2573251110 cites W1975775723 @default.
• W2573251110 cites W1979379023 @default.
• W2573251110 cites W198567900 @default.
• W2573251110 cites W1985762436 @default.
• W2573251110 cites W1987009448 @default.
• W2573251110 cites W1996405087 @default.
• W2573251110 cites W2010662888 @default.
• W2573251110 cites W2012369608 @default.
• W2573251110 cites W2014457594 @default.
• W2573251110 cites W2017397076 @default.
• W2573251110 cites W2024093005 @default.
• W2573251110 cites W2025561101 @default.
• W2573251110 cites W2032955576 @default.
• W2573251110 cites W2036223010 @default.
• W2573251110 cites W2038846160 @default.
• W2573251110 cites W2040142253 @default.
• W2573251110 cites W2054566387 @default.
• W2573251110 cites W2072077210 @default.
• W2573251110 cites W2075957912 @default.
• W2573251110 cites W2076915152 @default.
• W2573251110 cites W2079753094 @default.
• W2573251110 cites W2081928481 @default.
• W2573251110 cites W2091054988 @default.
• W2573251110 cites W2095156669 @default.
• W2573251110 cites W2098744444 @default.
• W2573251110 cites W2100439220 @default.
• W2573251110 cites W2101299592 @default.
• W2573251110 cites W2104239861 @default.
• W2573251110 cites W2107135201 @default.
• W2573251110 cites W2114139737 @default.
• W2573251110 cites W2115261608 @default.
• W2573251110 cites W2122983196 @default.
• W2573251110 cites W2124511021 @default.
• W2573251110 cites W2126816162 @default.
• W2573251110 cites W2132960405 @default.
• W2573251110 cites W2136527721 @default.
• W2573251110 cites W2139135964 @default.
• W2573251110 cites W2141393790 @default.
• W2573251110 cites W2151425644 @default.
• W2573251110 cites W2156706402 @default.
• W2573251110 cites W2161428561 @default.
• W2573251110 cites W2163494169 @default.
• W2573251110 cites W2165003903 @default.
• W2573251110 cites W2166199281 @default.
• W2573251110 cites W2226378560 @default.
• W2573251110 cites W2419599820 @default.
• W2573251110 cites W2513632505 @default.
• W2573251110 hasPublicationYear "2015" @default.
• W2573251110 type Work @default.
• W2573251110 sameAs 2573251110 @default.
• W2573251110 citedByCount "0" @default.
• W2573251110 crossrefType "journal-article" @default.
• W2573251110 hasAuthorship W2573251110A5080246490 @default.
• W2573251110 hasConcept C121608353 @default.
• W2573251110 hasConcept C153911025 @default.
• W2573251110 hasConcept C159654299 @default.
• W2573251110 hasConcept C185592680 @default.
• W2573251110 hasConcept C195616568 @default.
• W2573251110 hasConcept C203014093 @default.
• W2573251110 hasConcept C2779786085 @default.
• W2573251110 hasConcept C2781164504 @default.
• W2573251110 hasConcept C502942594 @default.
• W2573251110 hasConcept C530470458 @default.
• W2573251110 hasConcept C54355233 @default.
• W2573251110 hasConcept C55493867 @default.
• W2573251110 hasConcept C62112901 @default.
• W2573251110 hasConcept C81885089 @default.
• W2573251110 hasConcept C86803240 @default.
• W2573251110 hasConceptScore W2573251110C121608353 @default.
• W2573251110 hasConceptScore W2573251110C153911025 @default.
• W2573251110 hasConceptScore W2573251110C159654299 @default.
• W2573251110 hasConceptScore W2573251110C185592680 @default.
• W2573251110 hasConceptScore W2573251110C195616568 @default.
• W2573251110 hasConceptScore W2573251110C203014093 @default.
• W2573251110 hasConceptScore W2573251110C2779786085 @default.
• W2573251110 hasConceptScore W2573251110C2781164504 @default.
• W2573251110 hasConceptScore W2573251110C502942594 @default.
• W2573251110 hasConceptScore W2573251110C530470458 @default.
• W2573251110 hasConceptScore W2573251110C54355233 @default.
• W2573251110 hasConceptScore W2573251110C55493867 @default.
• W2573251110 hasConceptScore W2573251110C62112901 @default.
• W2573251110 hasConceptScore W2573251110C81885089 @default.
• W2573251110 hasConceptScore W2573251110C86803240 @default.
• W2573251110 hasLocation W25732511101 @default.
• W2573251110 hasOpenAccess W2573251110 @default.
• W2573251110 hasPrimaryLocation W25732511101 @default.

• next